Here we document an extensive characterization of the STING pathway in human HNSCC cell lines and primary human tissues and reveal fundamental differences in the STING protein expression, downstream signaling, and functional modulation of immune responses by the HPV+ and HPV− tumor types. The gene discussed is STING1; the disease is head and neck squamous cell carcinoma.